Michelle M. Giddens, B.S.

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Owino S, Giddens MM, Jiang JG, et al. (2021) GPR37 modulates progenitor cell dynamics in a mouse model of ischemic stroke. Experimental Neurology. 113719
Nguyen TT, Dammer EB, Owino SA, et al. (2020) Quantitative Proteomics Reveal an Altered Pattern of Protein Expression in Brain Tissue from Mice Lacking GPR37 and GPR37L1. Journal of Proteome Research
McCrary MR, Jiang MQ, Giddens MM, et al. (2019) Protective effects of GPR37 regulation of inflammation and multiple cell death pathways after ischemic stroke in mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201900070R
Giddens MM, Wong JC, Schroeder JP, et al. (2017) GPR37L1 modulates seizure susceptibility: Evidence from mouse studies and analyses of a human GPR37L1 variant. Neurobiology of Disease
Smith BM, Giddens MM, Neil J, et al. (2017) Mice lacking Gpr37 exhibit decreased expression of the myelin-associated glycoprotein MAG and increased susceptibility to demyelination. Neuroscience
Meyer RC, Giddens MM, Coleman BM, et al. (2014) The protective role of prosaposin and its receptors in the nervous system. Brain Research. 1585: 1-12
Meyer RC, Giddens MM, Schaefer SA, et al. (2013) GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin. Proceedings of the National Academy of Sciences of the United States of America. 110: 9529-34